Ally Bridge Group as of Sept. 30, 2023
Portfolio Holdings for Ally Bridge Group
Ally Bridge Group holds 19 positions in its portfolio as reported in the September 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 12.3 | $10M | 183k | 57.00 | |
| Xenon Pharmaceuticals (XENE) | 10.7 | $9.1M | 267k | 34.16 | |
| Intra Cellular Therapies (ITCI) | 10.7 | $9.1M | 175k | 52.09 | |
| Axsome Therapeutics (AXSM) | 9.1 | $7.7M | 111k | 69.89 | |
| Apellis Pharmaceuticals (APLS) | 8.1 | $6.9M | 182k | 38.04 | |
| Cytokinetics Com New (CYTK) | 7.7 | $6.6M | 223k | 29.46 | |
| Merus N V (MRUS) | 6.1 | $5.2M | 221k | 23.58 | |
| Amylyx Pharmaceuticals (AMLX) | 5.9 | $5.0M | 273k | 18.31 | |
| Geron Corporation (GERN) | 5.5 | $4.7M | 2.2M | 2.12 | |
| Ardelyx (ARDX) | 4.2 | $3.6M | 881k | 4.08 | |
| Ambrx Biopharma Sponsored Ads | 3.8 | $3.2M | 281k | 11.50 | |
| Mirati Therapeutics | 3.6 | $3.1M | 70k | 43.56 | |
| Jasper Therapeutics | 2.6 | $2.2M | 3.1M | 0.70 | |
| Black Diamond Therapeutics (BDTX) | 2.1 | $1.8M | 634k | 2.87 | |
| Praxis Precision Medicines I | 2.1 | $1.8M | 1.1M | 1.71 | |
| Compass Therapeutics (CMPX) | 2.1 | $1.8M | 915k | 1.97 | |
| Context Therapeutics (CNTX) | 1.3 | $1.1M | 726k | 1.51 | |
| Promis Neurosciences Com New (PMN) | 1.2 | $1.1M | 532k | 1.98 | |
| Medavail Holdings Com New (MDVLQ) | 0.8 | $707k | 118k | 6.00 |
